Nuray Cakici
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia.
Journal: Psychiatry research
Published: May 22, 2024
Cross-sectional association between metabolic parameters and psychotic-like experiences in a population-based sample of middle-aged and elderly individuals.
Journal: Schizophrenia research
Published: March 09, 2022
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Journal: Psychological medicine
Published: March 03, 2021
Reply to interleukin-6 in schizophrenia: Cause of death matters.
Journal: Brain, behavior, and immunity
Published: August 26, 2020
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis.
Journal: Psychological medicine
Published: August 24, 2019
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Journal: Brain, behavior, and immunity
Published: June 26, 2019
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 15, 2018
Systematic review of treatments for diabetic peripheral neuropathy.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: January 25, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026